Allergy and Clinical Immunology

1992-96. Ricercatore Universitario in Malattie Infettive (tenured Lectureship in Infectious Diseases), University of Messina, Italy. 1997. Research Associate at the University of Newcastle, Department of Microbiology, The Medical School, Newcastle upon Tyne, UK. 1997-1999. Research Fellow, Department of Biochemistry, Imperial College of Science, Technology and Medicine, University of London, UK.1999-2004. University Lecturer in Microbiology, Department of Veterinary Medicine, University of Cambridge.2004-2008. University Senior Lecturer in Microbiology, Department of Veterinary Medicine, University of Cambridge.

Recent research is focused on pathogen behaviour (e.g. location, growth, spread in the body, gene regulation) in vivo at the single cell level in relation to immunity, vaccines and antibiotics. This work is delving into the bases of post-therapy microbial persistence and vaccine efficacy/failures. We use interdisciplinary research approaches that integrate information acquired at different levels spanning from individual cells to global systems. This work opens the field to high-impact research on new prevention measures and medical treatments.

Prof.Dr. Pichaet Wiriyachitra completed his PhD at the age of 27 years from University of Tasmania and postdoctoral studies from University of Connecticut and University of Pennsylvania. He served in the Prince of Sonkla University and Chiang Mai University for 26 years and published 80 scientific papers in reputed journals both in Thai and English. He is the CEO of Asian Phytoceuticals Public Company Limited and the principal investigator of Operation BIM Research Team consisting of Assoc.Prof.Dr. Ampai Panthong, Prof.Dr. Souwalak Phongpaichit, Assoc.Prof.Dr. Wilawan Mahabussarakam and Assoc.Prof.Dr. Siriwan Ong-chai..

Pichaet Wiriyachitra research interest is based on Immunology, Immunotherapy And Vaccine

Professor Teruna Siahaan earned a B.S. and an M.S. from the University of Indonesia and a Ph.D. from the University of Arizona. He completed a postdoctoral fellowship at the University of California, Santa Barbara.

Professor Siahaan's research interests are in the utilization and modulation of cell adhesion molecules on the cell surface for targeted drug delivery to a specific cell type and for enhancing drug permeation through the intestinal mucosa and blood-brain barrier (BBB). Dr. Siahaan’s group is using E-cadherin peptides to enhance permeation of large hydrophilic molecules (i.e., peptides and proteins) through the intestinal mucosa and BBB. The hypothesis is that E-cadherin peptides modulate the E-cadherin interactions at the intercellular junctions to create larger openings that will allow paracellular permeation of large hydrophilic molecules (e.g., peptides and proteins). His group is also using peptides derived from cell adhesion molecules (i.e., ICAM-1 and LFA-1) to target drugs to leukocytes and vascular endothelial cells in inflammatory and autoimmune diseases (i.e., rheumatoid arthritis). Cell adhesion peptides are being used to target antigenic peptides (i.e., bi-functional peptide inhibitor (BPI)) to block the formation of the immunological synapse at the interface between T cells and antigen presenting cells (APC). BPI molecules have been shown to suppress autoimmune disease models such as multiple sclerosis, type-1 diabetes and rheumatoid arthritis.

Huang Wei Ling is graduated in medicine in Brazil, specializing in infectious and parasitic diseases, a General Practitioner and Parenteral and Enteral Medical Nutrition Therapist. She has been In Charge of the Hospital Infection Control Service of the City of Franca's General Hospital, she was responsible for the control of all prescribed antimicrobial medication, and received an award for the best paper presented at the Brazilian Hospital infection Control Congress in 1998. She was coordinator of both the Infection Control and the Nutritional Support Committee in Sao Joaquim Hospital in Franca, and also worked at the infectious Sexually Transmitted Disease Reference Center. She is the owner of the Medical Acupuncture and Pain Management Clinic, and since 1997 she has been presenting her work worldwide concerning the treatment of various diseases using techniques based on several medical traditions around the world. weili

Huang Wei Ling research interest is based on infectious and parasitic diseases, infectious Sexually Transmitted Disease. she has been presenting her work worldwide concerning the treatment of various diseases using techniques based on several medical traditions around the world.

Giulio Tarro graduated from Medicine School, Naples University (1962). Research Associate, Division of Virology and Cancer Research, Children’s Hospital (1965-1968), Assistant Professor of Research Pediatrics, College Medicine (1968-1969), Cincinnati University, Ohio. Oncological Virology Professor, Naples University (1972-1985). Chief Division Virology (1973-2003), Head Department Diagnostic Laboratories, (2003-2006). D. Cotugno Hospital for Infectious Diseases, Naples; Emeritus, 2006 -. Since 2007 Chairman Committee of Biotechnologies and VirusSphere, World Academy Biomedical Technologies, UNESCO, Adjunct Professor Department Biology, Temple University, College of Science and Technology, Philadelphia, recipient of the Sbarro Health Research Organization lifetime achievement award (2010). President Foundation de Beaumont Bonelli for Cancer Research.

Giulio Tarro research interest is based on Murine Virology, Antiviral Chemotherapy, Effects of inhibitors on viral replication, Studies on the role of herpesviruses in cancer, Tumor Immunology, Pathology of AIDS

Dr Michel Leclerc was born the 31 th of January 1941 at Saint Benoit sur Loire (France) He obtained his Master in Biological Sciences at the University of Orléans. He possessed a "D.E.S in Biology" and then a"Doctorat ès Sciences" in 1977 in this last University. Later he collaborated to the Institut Pasteur of Paris as a co-researcher for five years and then directed the laboratory of Immunology of Invertebrates, in the University of Orléans. He has been the first to culture invertebrate cells"in vitro" and more particurlaly sea star lymphocytes. In 1975 he spoke already in a paper at the Science Academy of France of Invertebrate antibody, in a world Where this last notion was" forbidden" ! Again he is the first to immunize sea stars with various antigens. In the years 1980 he published a papet at Eur.J.Immunol with Francis Delmotte et al, about the isolation and purification of Antibody-like substances in the sea star Asterias rubens.Then the last period comes with the genomics: He discovered the sea star IGKappa gene (2014) with 2 Ig sites. It is the first time we can speak of IAP (Invertebrate Primitive Antibody). So the Fab gene, the Fc receptor gene, the Cr gene. Besides the sea star Innate response, he spoke of ADAPTATIVE IMMUNITY in an Invertebrate for the first time. With 170 international publications, he said: "What is wrong yesterday is true to-day".

Dr Michel Leclerc research interset is based on Immunology, immunize sea stars with various antigens, isolation and purification of Antibody-like substances in the sea star.